Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB384723

Complement Component C1qA Antibody (C1QA/2952), DyLight 650, Novus Biologicals™
SDP

Catalog No. NB384723 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB384723 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB384723 Supplier Novus Biologicals Supplier No. NBP308746C
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Complement Component C1qA Monoclonal antibody specifically detects Complement Component C1qA in Human samples. It is validated for Immunohistochemistry (Paraffin), Protein Array

Specifications

Antigen Complement Component C1qA
Applications Immunohistochemistry (Paraffin), Protein Array
Classification Monoclonal
Clone C1QA/2952
Conjugate DyLight 650
Formulation 50mM Sodium Borate
Gene Alias C1QA complement component 1, q subcomponent, A chain
Host Species Mouse
Immunogen Recombinant fragment (around aa 104-237) of human Complement Component C1qA protein (exact sequence is proprietary) (Uniprot: P02745)
Purification Method Protein A or G purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Immunology, Innate Immunity
Primary or Secondary Primary
Gene ID (Entrez) 712
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2b κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.